About us
Read more about what we do, our vision, strategy and partnerships.
Our vision
Our vision has been co-created through consultation with the HDFT NHS Trust Cancer Board, staff across cancer services, patients and community representatives. The vision brings together the priorities outlined in the NHS England Long Term Plan: Ambitions for Cancer and those identified locally.
It focuses on 4 main themes:
- Best outcomes
- Local care provision
- The HDFT Experience
- Raising Profile
Harrogate and District NHS Foundation Trust
The HDFT NHS strategy
Follow this link to read more about the Harrogate and District NHS Foundation Trust’s strategy.
Our partnerships
These are organisations that we work closely with to provide our cancer services:
- Macmillan Cancer Support
- West Yorkshire and Harrogate Cancer Alliance
- North Yorkshire County Council
- Leeds Cancer Centre
- Maggie’s
- York Hospital
- NHS England
What we do
The Harrogate Cancer Unit sits within the Yorkshire and Humber Strategic Clinical Network. We diagnose more than 1,000 new patients per year and are consistently one of the top performing hospital trusts in the country for patient experience.
We provide the majority of treatments for common cancers locally and work closely with the Leeds Cancer Centre and York Teaching Hospital NHS Foundation Trust to provide treatment for patients with less common cancers. However, patients may still be seen in Harrogate for certain elements such as diagnostic or supportive care. All radiotherapy is provided at the Leeds Cancer Centre Bexley Wing.
Our experienced and skilled professionals specialise in many disciplines, and come together to work as Multidisciplinary Team (MDT) [link]. This ensures that our patients receive the best possible care and follow Timed Cancer Pathways [link]. All teams have the support of a Macmillan clinical nurse specialist to support patients through all stages.
Timed Cancer Pathways
We have timed diagnostic and treatment pathways in place for each of our cancer sites so that patients are aware of the approximate timings that they will be seen and treated by. The pathways have been developed in line with patient’s constitutional rights (Cancer Waiting Time standards), so that in most cases a diagnosis of cancer or non-cancer can be communicated to the patient by day 28 and the patient treated by day 62 (and within 31 days). Sometimes, the complexity of a diagnosis means that these timings cannot always be adhered to, and this will be explained to the patient as they move through their pathway.
Meet the Triumvirate Management Team
